EE427 Analyzing the Impact of the Inflation Reduction Act of 2022 on Biosimilars in the United States: A Simulation with Adalimumab
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.728
https://www.valueinhealthjournal.com/article/S1098-3015(23)00828-8/fulltext
Title :
EE427 Analyzing the Impact of the Inflation Reduction Act of 2022 on Biosimilars in the United States: A Simulation with Adalimumab
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00828-8&doi=10.1016/j.jval.2023.03.728
First page :
Section Title :
Open access? :
No
Section Order :
10203